Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Age-Related Differences in Hospitalization Rates, Clinical Presentation, and Outcomes Among Older Adults Hospitalized With Influenza-U.S. Influenza Hospitalization Surveillance Network (FluSurv-NET).

Czaja CA, Miller L, Alden N, Wald HL, Cummings CN, Rolfes MA, Anderson EJ, Bennett NM, Billing LM, Chai SJ, Eckel S, Mansmann R, McMahon M, Monroe ML, Muse A, Risk I, Schaffner W, Thomas AR, Yousey-Hindes K, Garg S, Herlihy RK.

Open Forum Infect Dis. 2019 Jul 1;6(7). pii: ofz225. doi: 10.1093/ofid/ofz225.

PMID:
31363771
2.

Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women - United States, 2008 and 2016.

McClung NM, Gargano JW, Park IU, Whitney E, Abdullah N, Ehlers S, Bennett NM, Scahill M, Niccolai LM, Brackney M, Griffin MR, Pemmaraju M, Querec TD, Cleveland AA, Unger ER, Markowitz LE; HPV-IMPACT Working Group.

MMWR Morb Mortal Wkly Rep. 2019 Apr 19;68(15):337-343. doi: 10.15585/mmwr.mm6815a1.

3.

Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.

Cleveland AA, Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Saadeh K, Pemmaraju M, Higgins K, Ehlers S, Scahill M, Johnson Jones ML, Querec T, Markowitz LE, Unger ER; HPV-IMPACT Working Group.

Int J Cancer. 2019 Apr 13. doi: 10.1002/ijc.32340. [Epub ahead of print]

PMID:
30980692
4.

Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008-2014.

McClung NM, Gargano JW, Bennett NM, Niccolai LM, Abdullah N, Griffin MR, Park IU, Cleveland AA, Querec TD, Unger ER, Markowitz LE; HPV-IMPACT Working Group.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):602-609. doi: 10.1158/1055-9965.EPI-18-0885. Epub 2019 Feb 21.

PMID:
30792242
5.

Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season.

Rolfes MA, Flannery B, Chung J, O'Halloran A, Garg S, Belongia EA, Gaglani M, Zimmerman R, Jackson ML, Monto AS, Alden NB, Anderson E, Bennett NM, Billing L, Eckel S, Kirley PD, Lynfield R, Monroe ML, Spencer M, Spina N, Talbot HK, Thomas A, Torres S, Yousey-Hindes K, Singleton J, Patel M, Reed C, Fry AM; U.S. Flu VE Network, the Influenza Hospitalization Surveillance Network (FluSurv-NET), and the Assessment Branch, Immunization Services Division, Centers for Disease Control and Prevention.

Clin Infect Dis. 2019 Feb 2. doi: 10.1093/cid/ciz075. [Epub ahead of print]

PMID:
30715278
6.

Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.

Milucky J, Carvalho MG, Rouphael N, Bennett NM, Talbot HK, Harrison LH, Farley MM, Walston J, Pimenta F, Lessa FC; Adult Pneumococcal Carriage Study Group.

Vaccine. 2019 Feb 14;37(8):1094-1100. doi: 10.1016/j.vaccine.2018.12.075. Epub 2019 Jan 23.

7.

Streptococcus infantis, Streptococcus mitis, and Streptococcus oralis Strains With Highly Similar cps5 Loci and Antigenic Relatedness to Serotype 5 Pneumococci.

Pimenta F, Gertz RE Jr, Park SH, Kim E, Moura I, Milucky J, Rouphael N, Farley MM, Harrison LH, Bennett NM, Bigogo G, Feikin DR, Breiman R, Lessa FC, Whitney CG, Rajam G, Schiffer J, da Gloria Carvalho M, Beall B.

Front Microbiol. 2019 Jan 8;9:3199. doi: 10.3389/fmicb.2018.03199. eCollection 2018.

8.

The Role of the Advisory Committee on Immunization Practices in Ensuring Optimal Use of Vaccines.

Bennett NM.

JAMA. 2019 Jan 29;321(4):341-342. doi: 10.1001/jama.2018.20792. No abstract available.

PMID:
30608510
9.

Streptococcus mitis Expressing Pneumococcal Serotype 1 Capsule.

Lessa FC, Milucky J, Rouphael NG, Bennett NM, Talbot HK, Harrison LH, Farley MM, Walston J, Pimenta F, Gertz RE, Rajam G, Carvalho MDG, Beall B, Whitney CG.

Sci Rep. 2018 Dec 19;8(1):17959. doi: 10.1038/s41598-018-35921-3.

10.

Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008-2015.

Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Johnson Jones ML, Whitney E, Pemmaraju M, Brackney M, Abdullah N, Scahill M, Dahl RM, Cleveland AA, Unger ER, Markowitz LE; HPV-IMPACT Working Group .

Clin Infect Dis. 2019 Apr 8;68(8):1282-1291. doi: 10.1093/cid/ciy707.

PMID:
30137283
11.

Social determinants of influenza hospitalization in the United States.

Chandrasekhar R, Sloan C, Mitchel E, Ndi D, Alden N, Thomas A, Bennett NM, Kirley PD, Hill M, Anderson EJ, Lynfield R, Yousey-Hindes K, Bargsten M, Zansky SM, Lung K, Schroeder M, Monroe M, Eckel S, Markus TM, Cummings CN, Garg S, Schaffner W, Lindegren ML.

Influenza Other Respir Viruses. 2017 Nov;11(6):479-488. doi: 10.1111/irv.12483. Epub 2017 Oct 6.

12.

The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder.

Belongia EA, Karron RA, Reingold A, Walter EB, Bennett NM.

Vaccine. 2018 Jan 8;36(3):343-344. doi: 10.1016/j.vaccine.2017.06.017. Epub 2017 Jul 3. No abstract available.

PMID:
28684166
13.

Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011.

Havers F, Sokolow L, Shay DK, Farley MM, Monroe M, Meek J, Daily Kirley P, Bennett NM, Morin C, Aragon D, Thomas A, Schaffner W, Zansky SM, Baumbach J, Ferdinands J, Fry AM.

Clin Infect Dis. 2016 Nov 15;63(10):1304-1311. Epub 2016 Aug 2.

PMID:
27486114
14.

Pneumococcal Disease Prevention Among Adults: Strategies for the Use of Pneumococcal Vaccines.

Pilishvili T, Bennett NM.

Am J Prev Med. 2015 Dec;49(6 Suppl 4):S383-90. doi: 10.1016/j.amepre.2015.09.008.

PMID:
26590438
15.

Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Kobayashi M, Bennett NM, Gierke R, Almendares O, Moore MR, Whitney CG, Pilishvili T.

MMWR Morb Mortal Wkly Rep. 2015 Sep 4;64(34):944-7. doi: 10.15585/mmwr.mm6434a4. Erratum in: MMWR Morb Mortal Wkly Rep. 2015 Oct 30;64(42):1204.

16.

Impact of Prompt Influenza Antiviral Treatment on Extended Care Needs After Influenza Hospitalization Among Community-Dwelling Older Adults.

Chaves SS, Pérez A, Miller L, Bennett NM, Bandyopadhyay A, Farley MM, Fowler B, Hancock EB, Kirley PD, Lynfield R, Ryan P, Morin C, Schaffner W, Sharangpani R, Lindegren ML, Tengelsen L, Thomas A, Hill MB, Bradley KK, Oni O, Meek J, Zansky S, Widdowson MA, Finelli L.

Clin Infect Dis. 2015 Dec 15;61(12):1807-14. doi: 10.1093/cid/civ733. Epub 2015 Sep 2.

PMID:
26334053
17.

Twenty Years of Active Bacterial Core Surveillance.

Langley G, Schaffner W, Farley MM, Lynfield R, Bennett NM, Reingold A, Thomas A, Harrison LH, Nichols M, Petit S, Miller L, Moore MR, Schrag SJ, Lessa FC, Skoff TH, MacNeil JR, Briere EC, Weston EJ, Van Beneden C.

Emerg Infect Dis. 2015 Sep;21(9):1520-8. doi: 10.3201/eid2109.141333.

18.

Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates.

Millman AJ, Reed C, Kirley PD, Aragon D, Meek J, Farley MM, Ryan P, Collins J, Lynfield R, Baumbach J, Zansky S, Bennett NM, Fowler B, Thomas A, Lindegren ML, Atkinson A, Finelli L, Chaves SS.

Emerg Infect Dis. 2015 Sep;21(9):1595-601. doi: 10.3201/eid2109.141665.

19.

Training in Infectious Disease Epidemiology through the Emerging Infections Program Sites.

Vugia DJ, Meek JI, Danila RN, Jones TF, Schaffner W, Baumbach J, Lathrop S, Farley MM, Tobin-D'Angelo M, Miller L, Harrison LH, Bennett NM, Cieslak PR, Cartter ML, Reingold AL.

Emerg Infect Dis. 2015 Sep;21(9):1516-9. doi: 10.3201/eid2109.150443.

20.

Emerging Infections Program Efforts to Address Health Equity.

Hadler JL, Vugia DJ, Bennett NM, Moore MR.

Emerg Infect Dis. 2015 Sep;21(9):1589-94. doi: 10.3201/eid2109.150275.

21.

Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.

Hariri S, Markowitz LE, Bennett NM, Niccolai LM, Schafer S, Bloch K, Park IU, Scahill MW, Julian P, Abdullah N, Levine D, Whitney E, Unger ER, Steinau M, Bauer HM, Meek J, Hadler J, Sosa L, Powell SE, Johnson ML; Hpv-Impact Working Group.

Emerg Infect Dis. 2015 Sep;21(9):1557-61. doi: 10.3201/eid2109.141841.

22.

Obesity not associated with severity among hospitalized adults with seasonal influenza virus infection.

Braun ES, Crawford FW, Desai MM, Meek J, Kirley PD, Miller L, Anderson EJ, Oni O, Ryan P, Lynfield R, Bargsten M, Bennett NM, Lung KL, Thomas A, Mermel E, Lindegren ML, Schaffner W, Price A, Chaves SS.

Infection. 2015 Oct;43(5):569-75. doi: 10.1007/s15010-015-0802-x. Epub 2015 Jul 7.

PMID:
26148927
23.

Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines.

Pilishvili T, Bennett NM.

Vaccine. 2015 Nov 27;33 Suppl 4:D60-5. doi: 10.1016/j.vaccine.2015.05.102. Epub 2015 Jul 9. Review.

PMID:
26116257
24.

Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States.

Hariri S, Johnson ML, Bennett NM, Bauer HM, Park IU, Schafer S, Niccolai LM, Unger ER, Markowitz LE; HPV-IMPACT Working Group.

Cancer. 2015 Aug 15;121(16):2775-81. doi: 10.1002/cncr.29266. Epub 2015 Jun 22.

25.

Estimating influenza disease burden from population-based surveillance data in the United States.

Reed C, Chaves SS, Daily Kirley P, Emerson R, Aragon D, Hancock EB, Butler L, Baumbach J, Hollick G, Bennett NM, Laidler MR, Thomas A, Meltzer MI, Finelli L.

PLoS One. 2015 Mar 4;10(3):e0118369. doi: 10.1371/journal.pone.0118369. eCollection 2015.

26.

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012.

Hariri S, Bennett NM, Niccolai LM, Schafer S, Park IU, Bloch KC, Unger ER, Whitney E, Julian P, Scahill MW, Abdullah N, Levine D, Johnson ML, Steinau M, Markowitz LE; HPV-IMPACT Working Group.

Vaccine. 2015 Mar 24;33(13):1608-13. doi: 10.1016/j.vaccine.2015.01.084. Epub 2015 Feb 11.

PMID:
25681664
27.

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.

Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, Petit S, Zansky SM, Harrison LH, Reingold A, Miller L, Scherzinger K, Thomas A, Farley MM, Zell ER, Taylor TH Jr, Pondo T, Rodgers L, McGee L, Beall B, Jorgensen JH, Whitney CG.

Lancet Infect Dis. 2015 Mar;15(3):301-9. doi: 10.1016/S1473-3099(14)71081-3. Epub 2015 Feb 3.

28.

HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States.

Hariri S, Unger ER, Schafer S, Niccolai LM, Park IU, Bloch KC, Bennett NM, Steinau M, Johnson ML, Markowitz LE; HPV-IMPACT Working Group.

Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):393-9. doi: 10.1158/1055-9965.EPI-14-0649. Epub 2014 Nov 21.

29.

Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, Hadler S, Pilishvili T; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5.

30.

Ranolazine refractory angina registry: 1-year results.

Bennett NM, Iyer V, Arndt TL, Garberich RF, Traverse JH, Johnson RK, Poulose AK, Lips A, Morgan JM, Henry TD.

Crit Pathw Cardiol. 2014 Sep;13(3):96-8. doi: 10.1097/HPC.0000000000000022.

PMID:
25062392
31.

Diastolic function with 16-phase gated myocardial perfusion SPECT.

Bennett NM, Qamruddin S, Colletti PM.

Clin Nucl Med. 2014 Jul;39(7):e355-8. doi: 10.1097/RLU.0000000000000458.

PMID:
24893129
32.

Complications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemic.

Reed C, Chaves SS, Perez A, D'Mello T, Daily Kirley P, Aragon D, Meek JI, Farley MM, Ryan P, Lynfield R, Morin CA, Hancock EB, Bennett NM, Zansky SM, Thomas A, Lindegren ML, Schaffner W, Finelli L.

Clin Infect Dis. 2014 Jul 15;59(2):166-74. doi: 10.1093/cid/ciu285. Epub 2014 Apr 29.

PMID:
24785230
33.

Child, household, and caregiver characteristics associated with hospitalization for influenza among children 6-59 months of age: an emerging infections program study.

Dharan NJ, Sokolow LZ, Cheng PY, Gargiullo P, Gershman K, Lynfield R, Morin C, Thomas A, Meek J, Farley MM, Arnold KE, Reingold A, Craig AS, Schaffner W, Bennett NM, Zansky S, Baumbach J, Lathrop S, Kamimoto L, Shay DK.

Pediatr Infect Dis J. 2014 Jun;33(6):e141-50. doi: 10.1097/INF.0000000000000283.

34.

Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009.

Wortham JM, Zell ER, Pondo T, Harrison LH, Schaffner W, Lynfield R, Thomas A, Reingold A, Bennett NM, Petit S, Aragon D, Bareta J, Juni BA, Farley MM, Beall B, Moore MR.

Clin Infect Dis. 2014 May;58(9):1250-7. doi: 10.1093/cid/ciu108. Epub 2014 Feb 27.

PMID:
24585565
35.

The burden of influenza hospitalizations in infants from 2003 to 2012, United States.

Chaves SS, Perez A, Farley MM, Miller L, Schaffner W, Lindegren ML, Sharangpani R, Meek J, Yousey-Hindes K, Thomas A, Boulton R, Baumbach J, Hancock EB, Bandyopadhyay AS, Lynfield R, Morin C, Zansky SM, Reingold A, Bennett NM, Ryan P, Fowler B, Fry A, Finelli L; Influenza Hospitalization Surveillance Network.

Pediatr Infect Dis J. 2014 Sep;33(9):912-9. doi: 10.1097/INF.0000000000000321.

PMID:
24577042
36.

Evaluating community engagement in an academic medical center.

Szilagyi PG, Shone LP, Dozier AM, Newton GL, Green T, Bennett NM.

Acad Med. 2014 Apr;89(4):585-95. doi: 10.1097/ACM.0000000000000190.

37.

Hospital-onset influenza hospitalizations--United States, 2010-2011.

Jhung MA, D'Mello T, Pérez A, Aragon D, Bennett NM, Cooper T, Farley MM, Fowler B, Grube SM, Hancock EB, Lynfield R, Morin C, Reingold A, Ryan P, Schaffner W, Sharangpani R, Tengelsen L, Thomas A, Thurston D, Yousey-Hindes K, Zansky S, Finelli L, Chaves SS.

Am J Infect Control. 2014 Jan;42(1):7-11. doi: 10.1016/j.ajic.2013.06.018. Epub 2013 Oct 30.

PMID:
24183534
38.

Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010.

Dawood FS, Chaves SS, Pérez A, Reingold A, Meek J, Farley MM, Ryan P, Lynfield R, Morin C, Baumbach J, Bennett NM, Zansky S, Thomas A, Lindegren ML, Schaffner W, Finelli L; Emerging Infections Program Network.

J Infect Dis. 2014 Mar 1;209(5):686-94. doi: 10.1093/infdis/jit473. Epub 2013 Aug 28.

PMID:
23986545
39.

Community needs, concerns, and perceptions about health research: findings from the clinical and translational science award sentinel network.

Cottler LB, McCloskey DJ, Aguilar-Gaxiola S, Bennett NM, Strelnick H, Dwyer-White M, Collyar DE, Ajinkya S, Seifer SD, O'Leary CC, Striley CW, Evanoff B.

Am J Public Health. 2013 Sep;103(9):1685-92. doi: 10.2105/AJPH.2012.300941. Epub 2013 Feb 14.

40.

Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children.

Muhammad RD, Oza-Frank R, Zell E, Link-Gelles R, Narayan KM, Schaffner W, Thomas A, Lexau C, Bennett NM, Farley MM, Harrison LH, Reingold A, Hadler J, Beall B, Klugman KP, Moore MR.

Clin Infect Dis. 2013 Mar;56(5):e59-67. doi: 10.1093/cid/cis971. Epub 2012 Nov 15.

PMID:
23155149
41.

Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions.

Powell SE, Hariri S, Steinau M, Bauer HM, Bennett NM, Bloch KC, Niccolai LM, Schafer S, Unger ER, Markowitz LE.

Vaccine. 2012 Dec 17;31(1):109-13. doi: 10.1016/j.vaccine.2012.10.092. Epub 2012 Nov 6.

PMID:
23137842
42.

Human papillomavirus genotypes in high-grade cervical lesions in the United States.

Hariri S, Unger ER, Powell SE, Bauer HM, Bennett NM, Bloch KC, Niccolai LM, Schafer S, Steinau M, Markowitz LE; HPV-IMPACT Working Group.

J Infect Dis. 2012 Dec 15;206(12):1878-86. doi: 10.1093/infdis/jis627. Epub 2012 Oct 8.

PMID:
23045628
43.

Increase in rates of hospitalization due to laboratory-confirmed influenza among children and adults during the 2009-10 influenza pandemic.

Cox CM, D'Mello T, Perez A, Reingold A, Gershman K, Yousey-Hindes K, Arnold KE, Farley MM, Ryan P, Lynfield R, Morin C, Baumbach J, Hancock EB, Zansky S, Bennett NM, Thomas A, Schaffner W, Finelli L; Emerging Infections Programs Network.

J Infect Dis. 2012 Nov;206(9):1350-8. doi: 10.1093/infdis/jis517. Epub 2012 Sep 21.

PMID:
23002448
44.

An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States.

Cohen AL, Taylor T Jr, Farley MM, Schaffner W, Lesher LJ, Gershman KA, Bennett NM, Reingold A, Thomas A, Baumbach J, Harrison LH, Petit S, Beall B, Zell E, Moore M.

PLoS One. 2012;7(8):e41785. doi: 10.1371/journal.pone.0041785. Epub 2012 Aug 1.

45.

Synthesis and characterization of luminescent cadmium selenide/zinc selenide/zinc sulfide cholinomimetic quantum dots.

Gégout C, McAtee ML, Bennett NM, Viranga Tillekeratne LM, Kirchhoff JR.

Nanoscale. 2012 Aug 7;4(15):4719-25. doi: 10.1039/c2nr30713h. Epub 2012 Jun 29.

PMID:
22744377
46.

Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic.

Garg S, Chaves SS, Pérez A, D'Mello T, Gershman K, Meek J, Yousey-Hindes K, Arnold KE, Farley MM, Tengelsen L, Ryan P, Sharangpani R, Lynfield R, Morin C, Baumbach J, Hancock EB, Zansky S, Bennett NM, Fowler B, Bradley K, Thomas A, Cooper T, Schaffner W, Boulton R, Finelli L, Fry AM.

Clin Infect Dis. 2012 Aug;55(3):e18-21. doi: 10.1093/cid/cis442. Epub 2012 Apr 27.

PMID:
22543024
47.

Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period.

De Serres G, Pilishvili T, Link-Gelles R, Reingold A, Gershman K, Petit S, Farley MM, Harrison LH, Lynfield R, Bennett NM, Baumbach J, Thomas A, Schaffner W, Beall B, Whitney C, Moore M.

Vaccine. 2012 Jun 8;30(27):4067-72. doi: 10.1016/j.vaccine.2012.04.017. Epub 2012 Apr 21.

PMID:
22525797
48.

Influenza-associated hospitalizations by industry, 2009-10 influenza season, United States.

Luckhaupt SE, Sweeney MH, Funk R, Calvert GM, Nowell M, D'Mello T, Reingold A, Meek J, Yousey-Hindes K, Arnold KE, Ryan P, Lynfield R, Morin C, Baumbach J, Zansky S, Bennett NM, Thomas A, Schaffner W, Jones T.

Emerg Infect Dis. 2012 Apr;18(4):556-62. doi: 10.3201/eid1804.110337.

49.

Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.

Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A, Harrison LH, Lynfield R, Bennett NM, Petit S, Gershman K, Baumbach J, Beall B, Jorgensen J, Glennen A, Zell ER, Moore M.

J Infect Dis. 2012 Feb 1;205(3):401-11. doi: 10.1093/infdis/jir755. Epub 2011 Dec 7.

PMID:
22158567
50.

The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions.

Hariri S, Unger ER, Powell SE, Bauer HM, Bennett NM, Bloch KC, Niccolai LM, Schafer S, Markowitz LE; HPV-IMPACT Working Group.

Cancer Causes Control. 2012 Feb;23(2):281-8. doi: 10.1007/s10552-011-9877-6. Epub 2011 Nov 23.

PMID:
22108842

Supplemental Content

Loading ...
Support Center